{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:41:30Z","timestamp":1783395690828,"version":"3.54.6"},"reference-count":13,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:p>\n            We analyzed the impact of vancomycin (VAN) combined with adjuvant \u03b2-lactam therapy (Combo) on persistent (\u22655\u2009days) methicillin-resistant\n            <jats:named-content content-type=\"genus-species\">Staphylococcus aureus<\/jats:named-content>\n            bacteremia versus VAN alone by using pooled data from two previously published observational studies (\n            <jats:italic>n<\/jats:italic>\n            \u2009=\u2009156). Combo was inversely associated with persistent bacteremia (adjusted odds ratio, 0.460; 95% confidence interval, 0.229 to 0.923).\n          <\/jats:p>","DOI":"10.1128\/aac.02211-18","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T12:26:49Z","timestamp":1546950409000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":12,"title":["Adjuvant \u03b2-Lactam Therapy Combined with Vancomycin for Methicillin-Resistant\n            <i>Staphylococcus aureus<\/i>\n            Bacteremia: Does \u03b2-Lactam Class Matter?"],"prefix":"10.1128","volume":"63","author":[{"given":"Thomas J.","family":"Dilworth","sequence":"first","affiliation":[{"name":"Aurora Health Care, Department of Pharmacy Services, Milwaukee, Wisconsin, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony M.","family":"Casapao","sequence":"additional","affiliation":[{"name":"University of Florida College of Pharmacy, Jacksonville, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar M.","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Independent Researcher, Gainesville, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9240-7067","authenticated-orcid":false,"given":"David M.","family":"Jacobs","sequence":"additional","affiliation":[{"name":"University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana R.","family":"Bowers","sequence":"additional","affiliation":[{"name":"Washington State University College of Pharmacy and Pharmaceutical Sciences, Yakima, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas D.","family":"Beyda","sequence":"additional","affiliation":[{"name":"University of Houston College of Pharmacy, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee-Claude","family":"Mercier","sequence":"additional","affiliation":[{"name":"University of New Mexico College of Pharmacy, Albuquerque, New Mexico, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01204-13"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2034"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ808"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01554-17"},{"key":"e_1_3_1_6_2","volume-title":"Abstr ID Week, 5 October 2017","author":"Trinh TD","year":"2017","unstructured":"Trinh TD, Zasowski EJ, Lagnf AM, Bhatia S, Dahr S, Mynatt R, Pogue JM, Rybak MJ. 2017. Combination vancomycin\/cefazolin (VAN\/CFZ) for methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections (BSI), abstr 777. Abstr ID Week, 5 October 2017, San Diego, CA."},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu583"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp080434"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-115-8-585"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix157"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1086\/313753"},{"key":"e_1_3_1_12_2","volume-title":"Abstr 27th Eur Congr Clin Microbiol Infect Dis","author":"Rose WE","year":"2017","unstructured":"Rose WE, McCreary EK, Schulz LT, Ouellette K, Vasina L, Geriak M, Sakoulas G. 2017. Reduced mortality of patients receiving daptomycin plus ceftaroline compared to standard monotherapy in MRSA bacteraemia: a matched case-control study, poster P2130. Abstr 27th Eur Congr Clin Microbiol Infect Dis, Vienna, Austria."},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-016-1295-3"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000002769"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02211-18","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02211-18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T21:29:04Z","timestamp":1645478944000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.02211-18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["10.1128\/AAC.02211-18"],"URL":"https:\/\/doi.org\/10.1128\/aac.02211-18","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"2018-10-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e02211-18"}}